Relentless Pursuit Partners

Relentless frames longevity as 'productive longevity,' meaning it invests explicitly in managing the progression of chronic diseases rather than only preventing them. The thesis accepts that 73% of people over 65 will live with at least one of the ten most common chronic conditions, so the portfolio includes devices like Orpyx Medical's pressure-sensing insoles for diabetic foot ulcers, not just wellness apps. The firm also treats exercise, music therapy, and personalized nutrition as clinical tools, evidenced by its investments in Lucid (music-based neurocognitive therapeutics) and VitaminLab.

The Relentless RoundUp serves as a direct channel for Managing Partner Brenda Irwin to articulate the firm's investment thesis through stories of personal health crises, family caregiving, and seasonal reflections on mental health, which reinforces the fund's brand as a values-driven health-tech investor. The 29th Edition, for example, cited her father's daily cycling routine as a proxy for the firm's mobility investment focus, turning a marketing tool into a narrative that aligns LPs with the fund's emotional and clinical logic. It also functions as a low-cost strategy to maintain visibility in Canada's niche health-tech startup community without paid marketing.